Logo image of NSIT

INSIGHT ENTERPRISES INC (NSIT) Stock Fundamental Analysis

USA - NASDAQ:NSIT - US45765U1034 - Common Stock

108.78 USD
-0.3 (-0.28%)
Last: 10/23/2025, 11:43:27 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NSIT. NSIT was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. While NSIT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NSIT is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

NSIT had positive earnings in the past year.
NSIT had a positive operating cash flow in the past year.
NSIT had positive earnings in each of the past 5 years.
Each year in the past 5 years NSIT had a positive operating cash flow.
NSIT Yearly Net Income VS EBIT VS OCF VS FCFNSIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

NSIT has a Return On Assets (1.71%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 9.32%, NSIT is in the better half of the industry, outperforming 71.54% of the companies in the same industry.
NSIT's Return On Invested Capital of 6.88% is fine compared to the rest of the industry. NSIT outperforms 69.92% of its industry peers.
NSIT had an Average Return On Invested Capital over the past 3 years of 11.53%. This is above the industry average of 9.33%.
The 3 year average ROIC (11.53%) for NSIT is well above the current ROIC(6.88%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.71%
ROE 9.32%
ROIC 6.88%
ROA(3y)4.44%
ROA(5y)4.4%
ROE(3y)15.82%
ROE(5y)14.97%
ROIC(3y)11.53%
ROIC(5y)11.25%
NSIT Yearly ROA, ROE, ROICNSIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.79%, NSIT perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
NSIT's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.23%, NSIT is in line with its industry, outperforming 59.35% of the companies in the same industry.
In the last couple of years the Operating Margin of NSIT has grown nicely.
Looking at the Gross Margin, with a value of 20.59%, NSIT is doing worse than 65.85% of the companies in the same industry.
In the last couple of years the Gross Margin of NSIT has grown nicely.
Industry RankSector Rank
OM 4.23%
PM (TTM) 1.79%
GM 20.59%
OM growth 3Y11.59%
OM growth 5Y7.81%
PM growth 3Y7.33%
PM growth 5Y6.89%
GM growth 3Y9.77%
GM growth 5Y6.63%
NSIT Yearly Profit, Operating, Gross MarginsNSIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NSIT is creating some value.
Compared to 1 year ago, NSIT has less shares outstanding
The number of shares outstanding for NSIT has been reduced compared to 5 years ago.
NSIT has a better debt/assets ratio than last year.
NSIT Yearly Shares OutstandingNSIT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NSIT Yearly Total Debt VS Total AssetsNSIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.81 indicates that NSIT is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of NSIT (1.81) is worse than 71.54% of its industry peers.
The Debt to FCF ratio of NSIT is 6.60, which is on the high side as it means it would take NSIT, 6.60 years of fcf income to pay off all of its debts.
NSIT has a Debt to FCF ratio (6.60) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.83 indicates that NSIT is somewhat dependend on debt financing.
The Debt to Equity ratio of NSIT (0.83) is worse than 85.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 6.6
Altman-Z 1.81
ROIC/WACC0.8
WACC8.61%
NSIT Yearly LT Debt VS Equity VS FCFNSIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

NSIT has a Current Ratio of 1.29. This is a normal value and indicates that NSIT is financially healthy and should not expect problems in meeting its short term obligations.
NSIT has a worse Current ratio (1.29) than 82.11% of its industry peers.
NSIT has a Quick Ratio of 1.26. This is a normal value and indicates that NSIT is financially healthy and should not expect problems in meeting its short term obligations.
NSIT has a Quick ratio of 1.26. This is in the lower half of the industry: NSIT underperforms 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.26
NSIT Yearly Current Assets VS Current LiabilitesNSIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

The earnings per share for NSIT have decreased by -8.06% in the last year.
NSIT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.97% yearly.
NSIT shows a decrease in Revenue. In the last year, the revenue decreased by -7.61%.
The Revenue has been growing slightly by 2.39% on average over the past years.
EPS 1Y (TTM)-8.06%
EPS 3Y10.83%
EPS 5Y12.97%
EPS Q2Q%-0.41%
Revenue 1Y (TTM)-7.61%
Revenue growth 3Y-2.66%
Revenue growth 5Y2.39%
Sales Q2Q%-3.25%

3.2 Future

NSIT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.20% yearly.
The Revenue is expected to grow by 2.37% on average over the next years.
EPS Next Y2.59%
EPS Next 2Y6.23%
EPS Next 3Y7.2%
EPS Next 5YN/A
Revenue Next Year-2.5%
Revenue Next 2Y1.16%
Revenue Next 3Y2.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NSIT Yearly Revenue VS EstimatesNSIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
NSIT Yearly EPS VS EstimatesNSIT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.62, which indicates a very decent valuation of NSIT.
NSIT's Price/Earnings ratio is rather cheap when compared to the industry. NSIT is cheaper than 95.94% of the companies in the same industry.
NSIT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.57.
A Price/Forward Earnings ratio of 9.96 indicates a reasonable valuation of NSIT.
Based on the Price/Forward Earnings ratio, NSIT is valued cheaply inside the industry as 95.94% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.09. NSIT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.62
Fwd PE 9.96
NSIT Price Earnings VS Forward Price EarningsNSIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NSIT is valued cheaply inside the industry as 86.18% of the companies are valued more expensively.
90.24% of the companies in the same industry are more expensive than NSIT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.05
EV/EBITDA 9.74
NSIT Per share dataNSIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NSIT does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of NSIT may justify a higher PE ratio.
PEG (NY)4.48
PEG (5Y)0.9
EPS Next 2Y6.23%
EPS Next 3Y7.2%

0

5. Dividend

5.1 Amount

No dividends for NSIT!.
Industry RankSector Rank
Dividend Yield N/A

INSIGHT ENTERPRISES INC

NASDAQ:NSIT (10/23/2025, 11:43:27 AM)

108.78

-0.3 (-0.28%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners107.18%
Inst Owner Change-0.58%
Ins Owners1.07%
Ins Owner Change1.01%
Market Cap3.42B
Revenue(TTM)8.36B
Net Income(TTM)149.67M
Analysts80
Price Target180.23 (65.68%)
Short Float %5.15%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.99%
Min EPS beat(2)-2.46%
Max EPS beat(2)0.48%
EPS beat(4)2
Avg EPS beat(4)-1.99%
Min EPS beat(4)-9.25%
Max EPS beat(4)3.28%
EPS beat(8)3
Avg EPS beat(8)0.16%
EPS beat(12)5
Avg EPS beat(12)0.67%
EPS beat(16)9
Avg EPS beat(16)3.94%
Revenue beat(2)0
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-5.97%
Max Revenue beat(2)-4.59%
Revenue beat(4)0
Avg Revenue beat(4)-6.59%
Min Revenue beat(4)-12.42%
Max Revenue beat(4)-3.37%
Revenue beat(8)1
Avg Revenue beat(8)-6.7%
Revenue beat(12)1
Avg Revenue beat(12)-6.75%
Revenue beat(16)5
Avg Revenue beat(16)-3.26%
PT rev (1m)4.85%
PT rev (3m)-5.39%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)0.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.88%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-2.7%
Valuation
Industry RankSector Rank
PE 11.62
Fwd PE 9.96
P/S 0.41
P/FCF 17.05
P/OCF 14.21
P/B 2.13
P/tB 11.17
EV/EBITDA 9.74
EPS(TTM)9.36
EY8.6%
EPS(NY)10.92
Fwd EY10.04%
FCF(TTM)6.38
FCFY5.86%
OCF(TTM)7.65
OCFY7.04%
SpS265.51
BVpS51.02
TBVpS9.74
PEG (NY)4.48
PEG (5Y)0.9
Graham Number103.65
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 9.32%
ROCE 9.21%
ROIC 6.88%
ROICexc 7.49%
ROICexgc 11.86%
OM 4.23%
PM (TTM) 1.79%
GM 20.59%
FCFM 2.4%
ROA(3y)4.44%
ROA(5y)4.4%
ROE(3y)15.82%
ROE(5y)14.97%
ROIC(3y)11.53%
ROIC(5y)11.25%
ROICexc(3y)12.54%
ROICexc(5y)12.1%
ROICexgc(3y)20.37%
ROICexgc(5y)19.03%
ROCE(3y)15.43%
ROCE(5y)15.05%
ROICexgc growth 3Y1.53%
ROICexgc growth 5Y6.87%
ROICexc growth 3Y-4.73%
ROICexc growth 5Y3.1%
OM growth 3Y11.59%
OM growth 5Y7.81%
PM growth 3Y7.33%
PM growth 5Y6.89%
GM growth 3Y9.77%
GM growth 5Y6.63%
F-Score6
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 6.6
Debt/EBITDA 2.9
Cap/Depr 38.8%
Cap/Sales 0.48%
Interest Coverage 250
Cash Conversion 52.76%
Profit Quality 134.14%
Current Ratio 1.29
Quick Ratio 1.26
Altman-Z 1.81
F-Score6
WACC8.61%
ROIC/WACC0.8
Cap/Depr(3y)78.59%
Cap/Depr(5y)73.34%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.5%
Profit Quality(3y)150.22%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.06%
EPS 3Y10.83%
EPS 5Y12.97%
EPS Q2Q%-0.41%
EPS Next Y2.59%
EPS Next 2Y6.23%
EPS Next 3Y7.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.61%
Revenue growth 3Y-2.66%
Revenue growth 5Y2.39%
Sales Q2Q%-3.25%
Revenue Next Year-2.5%
Revenue Next 2Y1.16%
Revenue Next 3Y2.37%
Revenue Next 5YN/A
EBIT growth 1Y-25.91%
EBIT growth 3Y8.62%
EBIT growth 5Y10.39%
EBIT Next Year5.1%
EBIT Next 3Y6.58%
EBIT Next 5YN/A
FCF growth 1Y-70.96%
FCF growth 3Y73.82%
FCF growth 5Y58.38%
OCF growth 1Y-66.92%
OCF growth 3Y56.95%
OCF growth 5Y37.68%